Helsinn Group Grants Exclusive Licensing Rights to Berlin-Chemie AG, a Company of the Menarini Group, for ONICIT®/ALOXI® and AKYNZEO® in Russia and CIS Region

Lugano, Switzerland and Berlin, Germany, Jan. 27 (Korea Bizwire) - Helsinn Group (“Helsinn”), a Swiss pharmaceutical group focused on building quality cancer care products, has granted exclusive licensing rights to commercialize AKYNZEO® and ONICIT® (ALOXI®) in Russia and the CIS region for the prevention of chemotherapy-induced nausea and vomiting (CINV) to Berlin-Chemie AG (“Berlin-Chemie”), the German-based affiliate of [...]